Conformation and dynamics of heparin and heparan sulfate

Glycobiology

Volumn 10, Issue 11, 2000, Pages 1147-1156

  Mulloy, B ^a   Forster, M J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

conformational analysis; Heparan sulfate; Heparin

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANTITHROMBIN; BASIC FIBROBLAST GROWTH FACTOR; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; CHONDROITIN SULFATE; COPOLYMER; DERMATAN SULFATE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GLUCOSAMINE; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HEPARIN DERIVATIVE; HYALURONIC ACID; IDURONIC ACID; KERATAN SULFATE; MONOSACCHARIDE; POLYSACCHARIDE; PYRANOSIDE; SERINE PROTEINASE; SULFATE;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; DRUG CONFORMATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; GEOMETRY; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0033650826     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/10.11.1147     Document Type: Article

References (72)

1. The use of CVFF and CFF91 force-fields in conformational analysis of carbohydrate molecules. Comparison with AMBER molecular mechanics and dynamics calculations for methyl α-lactoside
2. Crystalline structure of heparin
3. The effect of a reducing-end extension on pentasaccharide binding by antithrombin
4. Docking of glycosaminoglycans to heparin-binding proteins: Validation for aFGF, bFGF and antithrombin and application to IL-8
5. Determination of biomolecular structures from proton-proton NOEs using a relaxation matrix approach
6. Computational challenges for macro-molecular structure determination by x-ray crystallography and solution NMR-spectroscopy
7. Molecular modeling of protein-glycosaminoglycan interactions
8. NMR analysis of carbohydrates with model-free spectral densities: The dispersion range revisited
9. Structural studies on a biologically active hexasaccharide obtained from heparin
10. Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
11. A general definition of ring puckering coordinates
12. Virtual and solution conformations of oligosaccharides
13. Structure of a heparin-linked biologically active dimer of fibroblast growth factor
14. Conformational analysis of the anomeric forms of sophorose, laminarabiose and cellobiose using MM3
15. Conformational analysis of the anomeric forms of kojibiose, nigerose and maltose using MM3
16. Pyranose ring flexibility. Mapping of physical data for iduronate in continous conformational space
17. Heparin structure and interactions with basic fibroblast growth factor
18. Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences
19. Treatment of ionic species in force field calculations: Sulfate and carboxylate groups in carbohydrates
20. Conformational analysis of heparin epoxide: Molecular mechanics computations
21. An improved force field for conformational analysis of sulfated polysaccharides
22. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
23. Molecular dynamics study of iduronate ring conformation
24. Rationalizing nuclear overhauser effect data for compounds adopting mutiple-solution conformations
25. NOEMOL: Integrated molecular graphics and the simulation of nuclear overhauser effects in NMR spectroscopy
26. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex
27. Studies on the conformation of heparin by 1H and 13C NMR spectroscopy
28. Constructing a molecular model of the interaction between antithrombin III and a potent heparin analogue
29. Picosecond dynamics of simple monosaccharides as probed by NMR and molecular dynamics simulations
30. Biosynthesis of heparin/heparan sulphate: Mechanism of epimerization of glucuronyl C-5
31. Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding regions
32. Solution dynamics of the 1,2,3,4,6,-penta-O-acetyl-alpha-D-idopyranose ring
33. Motional properties of E. coli polysaccharide K5 in aqueous solution analyzed by NMR relaxation measurements
34. Dynamics in aqueous solutions of the pentasaccharide corresponding to the binding site of heparin for anti-thrombin III studied by NMR relaxation measurements
35. Conformational analysis of heparin epoxide in aqueous solution. An NMR relaxation study
36. Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts
37. Investigation of (13)C relaxation and nuclear overhauser enhancement parameters for heparinoid systems: Comparison with data for dextrans
38. Force field parameters for sulfates and sulfamates based on ab initio calculations: Extensions of AMBER and CHARMm fields
39. Heparin is essential for the storage of specific granule proteases in mast cells
40. Stereographic representation of the Cremer-Pople ring-puckering parameters for pyranoid rings
41. The anticoagulant activation of antithrombin by heparin
42. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1
43. Proteoglycans: Master regulators of molecular encounter?
44. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin
45. Regulated diversity of heparan sulfate
46. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity
47. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results
48. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion
49. Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues
50. NMR solution conformation of heparin-derived tetrasaccharide
51. NMR solution conformation of heparin-derived hexasaccharide
52. The interaction between heparin and polylysine: A circular dichroism and molecular modeling study
53. N.m.r. and molecular-modeling studies of the solution conformation of heparin
54. The effect of variation of substitution on the solution conformation of heparin: A spectroscopic and molecular modeling study
55. Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites
56. A comparison and chemometric analysis of several molecular mechanics force fields and parameter sets applied to carbohydrates
57. Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-III
58. Correlation between structure and function of heparin
59. Characterization of the extent of internal motions in oligosaccharides
60. Conformational equilibria of α-L-iduronate residues in disaccharides derived from heparin
61. D-Idose: A one and two-dimensional NMR investigation of solution composition and conformation
62. Potential energy surfaces of cellobiose and maltose in aqueous solution: A new treatment of disaccharide optical rotation
63. Specific binding of the chemokine platelet factor 4 to heparan sulfate
64. Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain
65. Conformational analysis of synthetic heparin-like oligosaccharides containing α-L-idopyranosyluronic acid
66. Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor determined using two different algorithms, DISGEC and DISMAN
67. A flexible model for the cell wall polysaccharide of Streptococcus mitis J22 determined by three-dimensional (13)C edited nuclear overhauser effect spectroscopy and (13)C-(1)H long-range coupling constants combined modeling